RESUMO
RESUMO Os antibióticos como o norfloxacino constituem os fármacos mais utilizados na Medicina, com consumos expressivos no mundo todo. Por ser quimicamente estável, após sua administração a maior parte do fármaco é excretada de forma inalterada e, geralmente, é removida apenas parcialmente nas estações de tratamento de esgoto (ETEs). Assim, o presente trabalho buscou avaliar a eficiência dos processos biológicos na remediação de norfloxacino investigando os mecanismos de remoção envolvidos. O objetivo foi verificar a biodegradabilidade do fármaco e sua toxicidade. Para realização dos ensaios de biodegradabilidade, coletaram-se lodos na ETE Arrudas (Sabará, Minas Gerais) dos processos de tratamento com lodos ativados, reatores upflow anaerobic sludge blanket (UASB) e biodigestor anaeróbio. Reatores em escala de bancada foram montados com lodo aclimatado e não aclimatado. Amostras tiveram a biodegradabilidade acompanhada por meio da determinação do carbono orgânico total e da absortividade molar do norfloxacino por espectrofotometria de UV/Vis. Determinou-se a toxicidade por intermédio de ensaios com a bactéria Aliivibrio fischeri. Entre as biomassas utilizadas, a mais eficiente na remoção do norfloxacino foi advinda dos reatores UASB (23%), seguida do biodigestor anaeróbio (18%) e, então, dos lodos ativados (13%). Quanto à ecotoxicidade, a degradação anaeróbia promoveu a eliminação da toxicidade do antibiótico, enquanto com relação à degradação aeróbia os efluentes gerados permanecem tóxicos.
ABSTRACT Antibiotics, such as norfloxacin, are the most widely used drugs in medicine, with significant consumption in the world. By being chemically stable, most of the drug is excreted unchanged after administration, and is generally only partially removed in the sewage treatment plants (STPs). Thus, the efficiency of biological processes in the remediation of norfloxacin was investigated by the present work, verifying the removal mechanisms involved. Its objective was to verify the drug's biodegradability and toxicity. In order to perform biodegradability tests, sludges were collected in Arrudas STP (Sabara, Minas Gerais) from the treatment processes with activated sludge, upflow anaerobic sludge blanket (UASB) reactors and anaerobic biodigester. Bench-scale reactors were assembled with acclimatized and non-acclimatized sludge. Samples had their biodegradability monitored by determination of total organic carbon and norfloxacin molar absorptivity by UV/Vis spectrophotometry. The toxicity was determined by tests with Aliivibrio fischeri. Among the used biomass, UASB reactors was the most efficient in removing norfloxacin (23%), followed by anaerobic biodigester (18%), and activated sludge (13%). Regarding ecotoxicity, the anaerobic degradation promoted the elimination of antibiotic toxicity, while with aerobic degradation, the effluents generated remained toxic.
RESUMO
The purpose of studying the biodegradability of pharmaceutical compounds is to evaluate their behaviors in relation to the treatment processes generally used in domestic and industrial wastewater treatment plants. The antibiotic norfloxacin was found to be a recalcitrant compound. The studies conducted showed norfloxacin removal rates of 12% and 18% when biomasses from treatments with activated sludge and anaerobic biodigesters, respectively, were used without acclimatization. This suggests that anaerobic digestion shows better performance for norfloxacin removal. Ecotoxicological tests, using the luminescent marine bacteria Aliivibrio fischeri as the test organism, show that anaerobic digestion could eliminate the toxicity of the antibiotic norfloxacin, even though total degradation of the drug was not observed. The release of norfloxacin during cell lysis suggests the importance of controlling this phenomenon in biological treatment systems that handle wastewater contaminated with norfloxacin, thus preventing the return of this drug to the environment.
